chr2-111778687-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_022662.4(ANAPC1):c.5373C>A(p.Ile1791=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 1.0 ( 55981 hom., cov: 13)
Exomes 𝑓: 1.0 ( 681220 hom. )
Failed GnomAD Quality Control
Consequence
ANAPC1
NM_022662.4 synonymous
NM_022662.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.137
Genes affected
ANAPC1 (HGNC:19988): (anaphase promoting complex subunit 1) This gene encodes a subunit of the anaphase-promoting complex. This complex is an E3 ubiquitin ligase that regulates progression through the metaphase to anaphase portion of the cell cycle by ubiquitinating proteins which targets them for degradation. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 2-111778687-G-T is Benign according to our data. Variant chr2-111778687-G-T is described in ClinVar as [Benign]. Clinvar id is 767814.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.137 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANAPC1 | NM_022662.4 | c.5373C>A | p.Ile1791= | synonymous_variant | 45/48 | ENST00000341068.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANAPC1 | ENST00000341068.8 | c.5373C>A | p.Ile1791= | synonymous_variant | 45/48 | 1 | NM_022662.4 | P1 | |
ANAPC1 | ENST00000427997.5 | c.3978C>A | p.Ile1326= | synonymous_variant | 34/37 | 1 | |||
ANAPC1 | ENST00000462785.1 | n.2067C>A | non_coding_transcript_exon_variant | 1/4 | 2 | ||||
ANAPC1 | ENST00000643447.1 | c.399C>A | p.Ile133= | synonymous_variant, NMD_transcript_variant | 5/12 |
Frequencies
GnomAD3 genomes AF: 0.998 AC: 112147AN: 112378Hom.: 55960 Cov.: 13
GnomAD3 genomes
AF:
AC:
112147
AN:
112378
Hom.:
Cov.:
13
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 1.00 AC: 202852AN: 202932Hom.: 101391 AF XY: 1.00 AC XY: 110359AN XY: 110390
GnomAD3 exomes
AF:
AC:
202852
AN:
202932
Hom.:
AF XY:
AC XY:
110359
AN XY:
110390
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 1.00 AC: 1362641AN: 1362842Hom.: 681220 Cov.: 20 AF XY: 1.00 AC XY: 682713AN XY: 682808
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1362641
AN:
1362842
Hom.:
Cov.:
20
AF XY:
AC XY:
682713
AN XY:
682808
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.998 AC: 112189AN: 112420Hom.: 55981 Cov.: 13 AF XY: 0.998 AC XY: 52577AN XY: 52692
GnomAD4 genome
AF:
AC:
112189
AN:
112420
Hom.:
Cov.:
13
AF XY:
AC XY:
52577
AN XY:
52692
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Rothmund-Thomson syndrome type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at